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A B S T R A C T
Background
Dysvascularity accounts for 75% of all lower limb amputations in the UK. Around 37% of these procedures are done at the transfemoral
level (mid-thigh), with most patients over the age of 60 and having existing comorbidities. A significant number of these amputees are
prescribed a lower limb prosthesis for walking. However, many amputees do not achieve a high level of function following prosthetic
rehabilitation. This is the third update of the review first published in 2005.
Objectives
To identify and summarise the evidence evaluating prosthetic rehabilitation interventions for prosthetic ambulation following unilateral
transfemoral or transgenicular amputation in older dysvascular people, whether community dwelling or institutionalised.
Search methods
The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register and CENTRAL, MEDLINE, Em-
base, and CINAHL databases; theWorldHealthOrganization International Clinical Trials Registry Platform; and the ClinicalTrials.gov
trials registry to 14 June 2018. We performed additional searches by handsearching citations of studies identified by the electronic
search. We applied no restrictions on language or publication status.
Selection criteria
Randomised and quasi-randomised controlled trials testing prosthetic rehabilitation interventions following a unilateral transfemoral
or transgenicular amputation in older (aged 60 years or older) dysvascular people.
Data collection and analysis
Two review authors independently scanned the search results for potentially eligible studies and, on obtaining full reports of these,
selected studies for inclusion and exclusion. Two review authors independently assessed the methodological quality of studies and
extracted data. We used GRADE to assess the overall quality of evidence supporting the outcomes assessed in this review.
Main results
We identified no new studies for inclusion in this update. In total we included one trial, excluded 18 trials, classed one trial as ongoing,
and classed another as awaiting classification. The total number of participants in the included trial was 10, and the methodological
quality of this trial was moderate because of high risk of bias in relation to two domains (random sequence generation and allocation
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concealment) but low risk of bias for the four remaining domains (blinding, incomplete outcome data, selective reporting, and any
other bias). The included trial was a short-term cross-over randomised trial undertaken in Canada, which tested the effects of adding
three seemingly identical prosthetic weights (150 g vs 770 g vs 1625 g) to the prostheses of a total of 10 participants with unilateral
dysvascular transfemoral amputation. Eight participants were over 60 years of age. Trial authors found that four participants preferred
the addition of the lightest weight (150 g), five preferred the middle weight (770 g), and one preferred the heaviest weight (1625 g).
Researchers interpreted this as equating to user satisfaction (success) and reported no adverse effects.
Authors’ conclusions
The limited evidence presented in this review is of very low quality and is insufficient to inform the choice of prosthetic rehabilitation,
including the optimum weight of the prosthesis, after unilateral transfemoral amputation in older dysvascular people. A programme of
research that includes randomised controlled trials to examine key interventions is urgently required in this area.
P L A I N L A N G U A G E S U M M A R Y
Artificial limb rehabilitation for older people with a leg amputated at or above the knee because of blood circulation problems
Background
Problems with inadequate circulation in the legs (dysvascularity), particularly in people over the age of 60 years, can be so severe that
they need a leg amputated. This may occur as high as at or above the knee. Accompanying medical conditions (comorbidities) such
as diabetes and cardiovascular or heart disease can affect a person’s rehabilitation. When an above- or through-knee artificial limb
(prosthesis) is fitted, it is hard for the person to regain mobility and function, and some people choose to use a wheelchair. Motivation,
comfort, cosmetic appearance, functionality, reliability, ease of use, previous mobility, and the extra exertion needed to use an artificial
leg are all important factors that can affect a person’s independence and use of the prosthesis. Fear of falling, number of falls, social
circumstances, and help and support from other people are also important influences. The review authors searched for trials comparing
different types of rehabilitation that may benefit mobility or function in older people using an artificial limb.
Study characteristics and key results
Reviewers found only one controlled trial of moderate methodological quality (most recent search, 14 June 2018). This trial had a
cross-over design, and each of the 10 participants had three seemingly identical prosthetic weights added to the prosthesis below the
knee in random order. All artificial limbs were modular-style prostheses. The participants - nine men and one woman - were over 50
years of age, and eight were over 60 years old. Over the few hours of the trial, four participants preferred the lightest weight (150 g),
five preferred the medium weight (770 g), and one preferred the heaviest weight (1625 g). Seven of the 10 people successfully ranked
the weights from lightest to heaviest. The weights did not alter participants’ walking speed in a two-minute walk test. Study authors
reported no adverse effects.
Quality of the evidence and conclusions
The inclusion of only one trial with a small number of participants, short exposure to different weights in a laboratory setting, and
the fact that there were differences in weight between people and their prostheses limit the usefulness of these findings. The limited
evidence included in this review is of very low quality and is insufficient to inform the choice of prosthetic rehabilitation, including
optimum weight of the prosthesis, after unilateral transfemoral amputation in older dysvascular people.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Prosthet ic rehabilitat ion for older dysvascular people af ter a unilateral transfemoral amputat ion
Patient or population: adults over the age of 50 with a unilateral transfemoral amputat ion
Settings: community
Intervention: prosthet ic rehabilitat iona
Comparison: dif ferent rehabilitat ion
Outcomes No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Success of prosthetic rehabilitation (pref-
erence)
(1 day)
10 (1 RCT) ⊕©©©
Very lowb
Inclusion of only 1 trial with a small number of part icipants and
short exposure to dif ferent weights in a laboratory sett ing lim it
the usefulness of these f indings, and evidence is insuf f icient
to inform the choice of prosthet ic rehabilitat ion af ter unilateral
transfemoral amputat ion in older dysvascular people
Adverse effects
(1 day)
See comment. The study reported no adverse ef fects.
GRADE Working Group grades of evidence
High quality: f urther research is very unlikely to change our conf idence in the est imate of ef fect
Moderate quality: f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate
Low quality: f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate
Very low quality: we are very uncertain about the est imate
aFor the one included study (Meikle 2003), the intervent ion involved adding dif ferent weights below the knee joint to each
part icipant ’s prothesis in a single session. Trialists compared three weights in total and the study’s primary outcome
measure was preference. For this review, prosthet ic rehabilitat ion included the provision of a prescribed prosthesis post
amputat ion that was suitable for the individual’s needs with the aim of achieving an opt imum level of funct ion and mobility
following therapy intervent ion. Intervent ions that may form part of the prosthet ic rehabilitat ion package are described
under Types of intervent ions.
bEvidence was downgraded by three steps owing to risk of bias, imprecision in the results due to the small sample size, and
indirectness.
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B A C K G R O U N D
Description of the condition
More than 6000 leg amputations are performed in the United
Kingdom (UK) each year (ISD 2004), and more than two mil-
lion people with limb loss are reported to be living in the United
States (LLS 2000; Ziegler-Graham 2008). In 2009, amputation
was associated with hospital costs of USD8.3 billion in the United
States (HCUPNationwide Inpatient Sample (NIS) 2009). No or-
ganisation currently tracks the number of amputees worldwide.
However in the developing world, the leading cause of amputation
is trauma (Esquenazi 2004). A retrospective study undertaken in
Kolkata, India, identified the prevalence of traumatic lower limb
amputation to be 70.3% (Das Pooja 2013). The incidence of dys-
vascularity (poor circulation) increases with age, as does the pres-
ence of comorbidities (other medical conditions) such as diabetes.
In England, more than 90% of amputations performed in peo-
ple over the age of 50 are the result of peripheral arterial disease
(Moxley 2010). Approximately 55% of all lower limb amputa-
tions performed in the United States are the result of dysvascular-
ity (Ziegler-Graham 2008).
Description of the intervention
After the lower limb is amputated, a prosthesis (artificial leg) is
frequently prescribed, followed by a period of prosthetic rehabil-
itation. The primary aim of prosthetic rehabilitation for lower
limb amputees is to achievemaximumpatient independence safely,
with minimal extra energy expenditure and consideration of the
patient’s pre-amputation lifestyle, expectations, and medical lim-
itations (Broomhead 2012). It is reported that older dysvascular
unilateral transfemoral amputees do not achieve a high level of
prosthetic mobility or function, particularly in comparison with
transtibial (through the calf ) amputees. However, success rates
for prosthetic rehabilitation in this population differ markedly.
Davies 2003 found that only 25% of transfemoral amputees over
50 years of age achieved community mobility, and that this fig-
ure was reduced with advancing age. In contrast, an earlier study
found that only 4% of this population were community ambula-
tors (Houghton 1992).
Some studies have attempted to identify factors that contribute
to functional outcomes for amputees. These factors include psy-
chological and social aspects, the presence of comorbidities, and
age. Investigators have attempted to use such factors to predict
successful rehabilitation (Munin 2001). Clinical guidelines in the
UK recommend that patients should be made aware that concur-
rent pathologies and previous mobility affect realistic goal setting
and the outcomes of prosthetic rehabilitation (Broomhead 2012).
Success of prosthetic provision and rehabilitation is frequently
judged in terms of clinical measures of impairment or function, for
example, walking 45 m with the prosthesis (Munin 2001). How-
ever, the relationship between the amputee and his or her prosthe-
sis is potentially more complex, involving motivation, comfort,
cosmetic appearance, functionality, reliability, ease of use, and de-
gree of energy expenditure during use. Traditionally, self-reported
measures have been used to measure mobilisation with a prosthe-
sis. However advances in technology and the use of wearable de-
vices have made it possible for patients to measure more accurately
time spent using a prosthesis.
Transfemoral amputees have a greater level of disability and use
65% more energy than individuals with bipedal (normal) walking
(Waters 1976). The prevalence of coexisting cardiovascular disease
in patients with dysvascular amputation may be as high as 75%,
and comorbid heart disease may prevent patients from achieving
maximum functional independence (Roth 1998). Therefore, older
dysvascular transfemoral amputees with cardiac abnormalitiesmay
be at increased risk of an adverse event, such as heart failure, when
they are exercised during prosthetic rehabilitation.
Why it is important to do this review
Older people undergoing a unilateral transfemoral amputation
make up an increasingly important subgroup of amputees that has
been identified as having a low success rate with a prosthesis in
terms of functional mobility and usage. Healthcare professionals
involved in amputee rehabilitation need more evidence to sup-
port clinical decisions regarding the suitability of a patient in this
age group for prosthetic rehabilitation, especially when patient ex-
pectations do not match clinical decisions. Furthermore, patients
and carers have a right to good, evidence-based information on
which they can base their decisions regarding living either inde-
pendently or with care in the community. This includes assessing
whether mobility or function will be achievable with a prosthesis,
a wheelchair, or a combination of both. It is a professional’s duty
to discuss the advantages and disadvantages of each path and to
inform the patient of any associated clinical risk. It is important
to review available interventions that can improve rehabilitation
prospects. Therefore, we conducted this systematic review of evi-
dence related to prosthetic rehabilitation in older dysvascular uni-
lateral transfemoral amputees to inform clinical practice.
O B J E C T I V E S
To identify and summarise the evidence evaluating prosthetic re-
habilitation interventions with prosthetic ambulation following
unilateral transfemoral or transgenicular amputation in older dys-
vascular people, whether community dwelling or institutionalised.
M E T H O D S
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Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) and quasi-randomised trials
(e.g. randomised by date of birth or hospital record number) that
evaluated the success of prosthetic rehabilitation following a uni-
lateral transfemoral or transgenicular amputation in older dysvas-
cular people.
Types of participants
Male or female participants described as:
• older adults, elderly, veteran, geriatric, aged, seniors, or all
over the age of 60 years;
• living in the community or in institutional care;
and
• dysvascular; and
• having a unilateral transfemoral amputation, including
transgenicular (through the knee), and provided with a
transfemoral prosthesis for walking and functional rehabilitation.
Participant characteristics of interest included age, gender, previ-
ous level of mobility, and comorbidities.
Types of interventions
Prosthetic rehabilitation included provision of a prescribed pros-
thesis post amputation that was suitable for the individual’s needs,
with the aim of achieving an optimum level of function and mo-
bility following therapy intervention.
Interventions that may form part of the prosthetic rehabilitation
package included, but were not limited to:
• education on how to safely put on and take off the
prosthesis, dressing practice, and footwear provision;
• education on skin and residual skin care, hygiene of the
prosthesis and socks, and fit of the prosthesis;
• therapeutic interventions to increase muscle power and
range of movement, to improve core stability, and to optimise
gait and control of the prosthesis;
• balance and mobility training whilst wearing the prosthesis,
including in different environments, negotiating hazards, and
getting up from a fall;
• training in functional activities of daily living, including
domestic activities; and
• general advice (e.g. where to seek help, aids, adaptations,
driving, support groups, return to work).
We considered trials in which participants were randomised to
receive any combination of the following: usual care, a single-
therapy intervention, or a multiple-therapy intervention. We also
planned to include trials comparing two or more interventions.
We considered trials that focused on prosthetic rehabilitation and
included the provision of a prescribed prosthesis post amputation
that was suitable for the individual’s needs, with the aim of achiev-
ing an optimum level of function and mobility following therapy
intervention. Interventions could include education on safe don-
ning and doffing of the prosthesis, dressing practice, and footwear
provision. We also considered interventions that focused on skin
care for the residual limb, including hygiene of the prosthesis and
socks, and prosthetic fit. In addition, we considered for inclusion
therapeutic interventions that focused on increasing muscle power
and range of movement, as well as providing re-education for gait
and activities of daily living; and studies that focused on provid-
ing advice and support in relation to driving or returning to em-
ployment and leisure activities. Therapy interventions could take
place in the home, an institutional dwelling, the community, a
gymnasium, or a clinic setting, and they could be self-supervised
(e.g. using exercise sheets or a video), individually supervised, or
given in the setting of a supervised group.
Types of outcome measures
The primary outcome of interest was ’success’ as defined below.
We classified outcome measures according to the dimensions of
the International Classification of Functioning, Disability, and
Health (ICF) (WHO 2001): impairment, activity limitation, and
participation restriction.
Primary outcomes
• Success: based on comfort, cosmetic appearance, frequency
of prosthetic use, satisfaction for purpose, levels of function, and
independence. Measures or scales included Prosthetic Socket Fit
Comfort Score, Harold-Wood Stanmore Mobility Grades,
Locomotor Capabilities Index, Rivermead Mobility Index,
Prosthesis Evaluation Questionnaire, Satisfaction With
Prosthesis Questionnaire, Functional Measure for Amputees, and
Russek’s Scale
• Adverse effects
Secondary outcomes
• Quality of life (QoL): measured by Sickness Impact Profile,
Nottingham Health Profile, and Medical Outcomes Study
(MOS) Short Form (SF)-36 (or others)
• Morbidity and comorbidities
• Mortality
• Compliance with rehabilitation
• Psychological distress (anxiety or depression, or both)
• Discharge setting and level of wheelchair use
• Indicators of previous level of mobility
• Number of falls experienced
• Problems associated with dysvascularity of the remaining
limb
• Sensory impairment
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• Risk of falls and fear of falling
• Social circumstances and level of support available or
required
Search methods for identification of studies
Weapplied no restrictions on language or publication status during
the search.
Electronic searches
For this update, the Cochrane Vascular Information Specialist first
searched the following databases for relevant trials.
• Cochrane Vascular Specialised Register (16 January 2017).
• Cochrane Central Register of Controlled Trials
(CENTRAL; 2016, Issue 11), in the Cochrane Library, via the
Cochrane Register of Studies Online.
See Appendix 1 for details of the search strategy used to search
CENTRAL.
The Information Specialist searched the following trial registries
for details of ongoing and unpublished studies.
• ClinicalTrials.gov (clinicaltrials.gov).
• World Health Organization International Clinical Trials
Registry Platform ( who.int/trialsearch).
• International Standard Randomized Controlled Trials
Number ( ISRCTN) Register ( isrctn.com/).
See Appendix 2 for details of the search strategy used to search
trial registries.
The Cochrane Vascular Information Specialist subsequently con-
ducted a top-up search of the following databases in June 2018.
• Cochrane Vascular Specialised Register via the Cochrane
Register of Studies (CRS-Web, searched to 15 June 2018).
• Cochrane Central Register of Controlled Trials
(CENTRAL), in the Cochrane Library, via the Cochrane
Register of Studies Online (CRSO) (2018, Issue 5).
• MEDLINE (Ovid MEDLINE® Epub Ahead of Print, In-
Process & Other Non-Indexed Citations, Ovid MEDLINE®
Daily, and Ovid MEDLINE®) (searched from 1 January 2017
to 14 June 2018).
• Embase Ovid (searched from 1 January 2017 to 15 June
2018).
• Cumulative Index to Nursing and Allied Health Literature
(CINAHL) Ebsco (searched from 1 January 2017 to 15 June
2018).
• Allied and Complementary Medicine Database (AMED)
Ovid (searched from 1 January 2017 to 15 June 2018).
The Information Specialist modelled search strategies for the listed
databases on the search strategy designed for CENTRAL. When
appropriate, we combined these strategies with adaptations of the
highly sensitive search strategy designed by Cochrane for identi-
fying RCTs and controlled clinical trials (as described in Chap-
ter 6 of the Cochrane Handbook for Systematic Reviews of Interven-
tions (Higgins 2011)). We have provided in Appendix 3 our search
strategies for the major databases.
The Information Specialist also performed top-up searches of the
following trials registries on 15 June 2018.
• World Health Organization International Clinical Trials
Registry Platform ( who.int/trialsearch).
• ClinicalTrials.gov ( clinicaltrials.gov).
Searching other resources
We performed additional searches by handsearching citations of
studies identified by the search.
Data collection and analysis
Selection of studies
From the title, abstract, and descriptors, two review authors (SB
and TH) independently reviewed results of the literature searches
to identify potentially relevant trials for full review. Upon review
of full texts, the same two review authors independently selected
for inclusion trials that met the selection criteria. We planned to
resolve disagreements by consensus.
Data extraction and management
If necessary, two review authors (SB and TH) would have inde-
pendently extracted data using a customised data extraction tool
that was tested before use. We extracted no new data for this up-
date. Contacting authors of studies was not necessary.We planned
to resolve disagreements by consensus.
Assessment of risk of bias in included studies
One review author (SB) assessed the included trial using
Cochrane’s ’Risk of bias’ tool as described in the Cochrane Hand-
book for Systematic Reviews of Interventions (Higgins 2011). This
tool measures risk of study bias with attention to randomisation,
allocation, blinding of participants and personnel, blinding of
outcome assessment, completeness of data, subsequent reporting
of data, and any other potential risk of bias. Review author TH
checked judgements.We planned to resolve disagreements by con-
sensus.
Measures of treatment effect
We planned to present quantitative data for the outcomes listed
in the inclusion criteria, when available and appropriate. For out-
comes with dichotomous data, we planned to present risk ratios
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(RRs) and 95% confidence intervals (CIs). For outcomes with
continuous data, we planned to present mean differences (MDs)
and 95% CIs.
Unit of analysis issues
We focused on the individual patient as the unit of analysis and
identified no unit of analysis issues in the included study.
Dealing with missing data
We planned to contact the study authors first via email if contact
information was available or by post to request any data that were
missing. When these data were not available, we planned to con-
duct an intention-to-treat analysis. This was not required, as the
included study provided a complete data set.
Assessment of heterogeneity
We planned to test heterogeneity between comparable trials using
a standard Chi² test, and we considered results to be statistically
significant at P < 0.1 after due consideration of the I² value. We
did not need to do this as only one study was included in the
review.
Assessment of reporting biases
We will test for publication bias using funnel plots if we identify
sufficient trials in future updates.
Data synthesis
We planned to undertake meta-analysis of the results of compa-
rable groups of trials using the fixed-effect model and 95% CIs.
As pooling of data was not possible because we included only one
study, we presented a narrative synthesis of study findings.
Subgroup analysis and investigation of heterogeneity
We planned to carry out separate outcome analyses to test the
following hypotheses when data were available.
• Prosthetic rehabilitation is equally successful in males and
females.
• Success does not depend on the duration and (or) intensity
of prosthetic rehabilitation.
• Success does not depend on the setting in which prosthetic
rehabilitation is delivered.
• Success does not depend on the level or type of supervision
provided for prosthetic rehabilitation.
Sensitivity analysis
We planned to perform sensitivity analyses, when indicated and
appropriate, to investigate the effects of allocation concealment,
methodological quality, and intention-to-treat analysis. This was
not possible as we included only one study.
’Summary of findings’ table
As we included only one study, we created a narrative summary of
findings table and included it in this review (Summary of findings
for the main comparison). This comprised the primary outcomes
of success and adverse effects (as described in Types of outcome
measures) related to the effectiveness of prosthetic rehabilitation in
older dysvascular unilateral transfemoral amputees. We presented
the number of total participants for each outcome.We assessed the
evidence for each outcome using the GRADE approach, which
grades the quality of the evidence as high, moderate, low, or very
low based on within-study risk of bias, directness of evidence,
heterogeneity, precision of effect estimates, and risk of publication
bias (Guyatt 2008).
R E S U L T S
Description of studies
Results of the search
See Figure 1.
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Figure 1. Study flow diagram.
For this update, we identified no new studies for inclusion. We
excluded 14 new studies (Agrawal 2015; Chin 2016; Christiansen
2018; Hafner 2015; Imam 2015; Madsen 2017; Mandel 2016;
Miller 2017; Morgan 2016; NCT03296904; NCT03376919;
NCT03433300; Samitier 2016; Simanic 2015), identified one
ongoing study (NCT01942798), and classed one study as awaiting
classification (NCT03094208).
Included studies
One study met the inclusion criteria, and we included it in this re-
view (Meikle 2003). This study was a cross-over randomised trial
that tested the effects of adding three seemingly identical pros-
thetic weights (150 g vs 770 g vs 1625 g) in a randomised order
to the prostheses of 10 amputees (Meikle 2003). All participants
had undergone transfemoral amputation for vascular reasons. The
mean age of participants was 65 years, although two participants
were between 50 and 60 years of age. One participant was female.
All participants were community ambulators who were at least
three months past their amputation and had similar activity levels.
This study compared the effects of adding three different weights
below the knee joint to each participant’s prosthesis during a single
session. The primary outcomemeasure was participant preference,
which was based on the rank order of preference of the partici-
pant for the three different weights. Researchers interpreted this
as equating to user satisfaction. The other main outcome measure
of the trial was participant gait speed as measured by the Two-
Minute Walk Test (2MWT).
Researchers also investigated participants’ ability to identify the
weight that had been added.
See the Characteristics of included studies table for summary de-
tails.
Excluded studies
8Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputation (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
We excluded a total of 18 studies (Agrawal 2015; Alexander
1978; Chin 2016; Christiansen 2018; Godfrey 1977;
Hafner 2015; Imam 2015; Madsen 2017; Mandel 2016;
Miller 2017; Morgan 2016; NCT03296904; NCT03376919;
NCT03433300; Presern-Strukel 2000; Samitier 2016; Simanic
2015; Wong 2002). See the Characteristics of excluded studies
table for summary details.
Ongoing studies
We identified one ongoing study (NCT01942798). See
Characteristics of ongoing studies for further details.
Studies awaiting classification
We classed one ongoing study as awaiting classification (
NCT03094208). We could consider this study in the future if
we were able to extract the data specifically for older adults. See
Characteristics of studies awaiting classification for further details.
Risk of bias in included studies
See Figure 2.
Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
We judged Meikle 2003 as being at high risk of bias for two do-
mains (random sequence generation and allocation concealment)
but at low risk of bias for the remaining four domains (blinding,
incomplete outcome data, selective reporting, and any other bias).
We have detailed this under Characteristics of included studies.
Allocation
Meikle 2003 used a randomised prospective cross-over design,
with all participants receiving all of the interventions (i.e. differing
weights added during their procedure). Study authors made no
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mention of the method used for sequence allocation or allocation
concealment of the interventions but stated that the interventions
were applied to each participant in randomised order.
Blinding
Both participants and the assessor were blinded to the interven-
tions (i.e. the weights added to the intervention), so we judged
Meikle 2003 to be at low risk of performance and detection bias.
Incomplete outcome data
Meikle 2003 was a laboratory-based study with no follow-up. All
participants completed the study.
Selective reporting
We found no evidence of selective reporting. Researchers included
and reported on all outcome data.
Other potential sources of bias
We identified no other sources of bias.
Effects of interventions
See: Summary of findings for the main comparison Prosthetic
rehabilitation for older dysvascular people after a unilateral
transfemoral amputation
We included only one study (Meikle 2003).
Meikle 2003 reported the primary outcome ’success’ in the form
of weight preference. Of 10 participants in the trial, four preferred
the placebo weight (150 g), five preferred 770 g, and one preferred
1625 g. Seven participants successfully ranked the weights from
lightest to heaviest. Meikle 2003 reported that results showed no
significant differences in participant gait speed when three differ-
ent weights were added to the prosthesis.
The authors of this study used the term ’weight’ rather than the
more correct term ’mass’ to describe additions to the prosthesis.
We have retained the study authors’ terminology in this review as
it is more commonly used outside the scientific community.
Meikle 2003 reported no adverse effects.
Meikle 2003 did not report on the secondary outcomes listed
under Types of outcome measures.
D I S C U S S I O N
Summary of main results
The included trial was a short-term cross-over randomised trial
that tested the effects of adding three seemingly identical pros-
thetic weights (150 g vs 770 g vs 1625 g) to the prostheses of 10
participants with unilateral dysvascular transfemoral amputation.
Eight participants were over 60 years of age. Trial authors found
that four participants preferred addition of the lightest weight (150
g), five preferred the middle weight (770 g), and one preferred the
heaviest weight (1625 g). As acknowledged by trialists in Meikle
2003, themost notable feature of the study results is that they chal-
lenge any assumption that patients will always prefer the lightest
prosthesis. Even this assertion must be seen in the context of the
very short-term nature of the intervention (a few hours). Other
issues also merit consideration. All interventions in this study were
identical (weight added to a prosthesis) and were assessed as ab-
solute values that were identical between participants. However,
the body weight of the individual participants varied from 52 kg
to 112 kg, thus the relative mass (weight) was different among
participants. The pre-intervention weight of the prosthesis used
by each participant also differed, from 2.8 to 4.2 kg. Therefore,
in both cases, the perceived weight that was added to the prosthe-
sis may have been different. Participants were permitted only five
to 10 minutes to familiarise themselves with the new prosthetic
weight before taking the walk test. It may have been that in this
population, participants would have benefited from a longer pe-
riod to acclimatise to the increased weight of the prosthetic limb.
Participants used their own prosthetic limbs; all were endoskele-
tal prostheses with modified quadrilateral sockets and the same
types of suspension. However, knee and foot prosthetic compo-
nents were not standardised among participants. These factors -
individually or in combination - could potentially confound the
results of this study. Meikle 2003 trialists also acknowledge the
difficulties of performing trials in a rehabilitation setting, where
the question under study and interpretation of findings may not
be quite as straightforward as they initially appear.
Certainly, research on the optimum weight of a prosthetic limb
in this population would be useful. Such research should include
assessment of the high energy expenditure costs that older unilat-
eral dysvascular transfemoral amputees are known to experience
in the presence of comorbidities. A much larger sample size, stan-
dardisation of prosthetic components, randomisation into sepa-
rate treatment groups, longer trial duration, and appropriate fol-
low-up may provide the necessary clinically relevant data on the
optimum weight of a prosthetic limb for this population.
Overall completeness and applicability of
evidence
We aimed to identify and summarise the evidence from ran-
domised controlled trials evaluating prosthetic rehabilitation in-
terventions for prosthetic ambulation following unilateral trans-
femoral or transgenicular amputation in older dysvascular people.
The limited evidence identified and summarised has not suffi-
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ciently addressed the expressed objectives of this review. Although
the weight of an amputee’s prosthetic limb is clinically important,
particularly from the point of view of amputee satisfaction, the
included study provided only minimal evidence of effect. Indeed,
the small number of participants, limitations of the cross-over de-
sign, the short duration of the intervention, the laboratory nature
of the trial, the absence of follow-up, and the limited nature of
outcome assessment prevent such a trial from providing adequate
evidence to inform the prescription of prosthetic limbs. We did
not identify studies that evaluated the effectiveness of prosthetic
rehabilitation interventions to improve prosthetic ambulation in
this important subgroup of lower limb amputees.
Quality of the evidence
Only one randomised trial with 10 participants satisfied the eli-
gibility criteria for this review (Meikle 2003). The overall quality
of the evidence was very low. We downgraded the quality of the
evidence owing to high risk of bias in relation to two domains
(random sequence generation and allocation concealment), im-
precision due to the small sample size, and indirectness, as the
study fails to address the review question.
Older people with a unilateral transfemoral amputation are an
increasingly important subgroup of amputees identified as having
a low success rate with a prosthesis, in terms of functional mobility
and usage. It is disappointing, therefore, that there is a paucity
of good quality and reliable research evidence that can be used to
inform clinical practice.
Potential biases in the review process
Weused a systematic approach to our search for evidence. Study se-
lection and data extraction methods followed those recommended
in the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011). The search was sufficiently broad to include
both published and unpublished evidence and included relevant
databases, handsearching, and contact with experts in the field.We
placed no language restrictions on the searches nor on inclusion
of studies. We are confident that we have included all available
evidence in this field. The main limitation of this review is that we
identified and summarised only one study of moderate quality.
Agreements and disagreements with other
studies or reviews
We have found no other similar reviews dealing with this popu-
lation for comparison with the findings of this review. Deficiency
of evidence may also apply to other transfemoral amputee groups.
We did identify a randomised controlled trial evaluating the fea-
sibility of a Wii Fit intervention for improving walking in older
adults with a lower limb amputation (Imam 2015). However this
study included a mixed population of transtibial and transfemoral
amputees with mixed causes of amputation. Investigators noted a
medium effect favouring the Wii.n.Walk intervention group for
the Two-Minute Walk Test. Results of this trial suggest that older
lower limb amputees would benefit from larger randomised con-
trolled trials conducted to determine the efficacy of the Wii as
an intervention provided during prosthetic rehabilitation to im-
prove walking in this group. We also identified one randomised
controlled study investigating the effects of a therapeutic interven-
tion during the prosthetic rehabilitation of young traumatic trans-
femoral amputees (Yigiter 2002). This trial found that proprio-
ceptive neuromuscular facilitation was more effective than tradi-
tional training for gait and weight bearing in younger traumatic
unilateral transfemoral amputees. Few high-quality studies have
investigated the effectiveness of prosthetic rehabilitation in lower
limb amputees of all ages and levels, with variable causation.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The limited evidence included in this review is insufficient to in-
form the choice of prosthetic rehabilitation, including the opti-
mum weight of a prosthesis, after unilateral transfemoral amputa-
tion in older dysvascular people.
Implications for research
Most research in this area of clinical practice has been reported by
cohort studies and has been based upon prognostic indicators of
success. These have included psychological and cognitive aspects,
comorbidities, functional abilities, compliance, and use of assess-
ment tools. This is not enough to inform practice. Reliable evi-
dence is urgently needed from high-quality and sufficiently pow-
ered randomised controlled trials exploring the success (e.g. user
satisfaction based on comfort, cosmetic appearance, frequency of
prosthetic use, satisfaction for purpose, levels of function, and in-
dependence) of key prosthetic rehabilitation interventions follow-
ing transfemoral amputation in older dysvascular people. Research
topic priorities informed by clinicians and amputees must be as-
certained before a research programme can be set up to address
important questions in this clinical area.
A C K N OW L E D G E M E N T S
We would like to acknowledge the contributions of Jane Cum-
ming, who was the lead author on the original review and subse-
quent updates. She conceived the review and designed the proto-
col alongside the co-review authors. She led the development and
11Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputation (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
running of search strategies, study selection, review of the included
study, and production of drafts of the review.
R E F E R E N C E S
References to studies included in this review
Meikle 2003 {published data only}
Meikle B, Boulias C, Pauley T, Devlin M. Does increased
prosthetic weight affect gait speed and patient preference
in dysvascular transfemoral amputees?. Archives of Physical
Medicine and Rehabilitation 2003;84(11):1657–61.
CN–00453251]
References to studies excluded from this review
Agrawal 2015 {published data only}
Agrawal V, Gailey RS, Gaunaurd IA, et al. Comparison
of four different categories of prosthetic feet during ramp
ambulation in unilateral transtibial amputees. Prosthetics
and Orthotics International 2015;39:380–9.
Alexander 1978 {published data only}
Alexander J, Goodrich R. Videotape immediate playback: a
tool in rehabilitation of persons with amputations. Archives
of Physical Medicine and Rehabilitation 1978;59(3):141–4.
Chin 2016 {published data only}
Chin T, Toda M. Results of prosthetic rehabilitation on
managing transtibial vascular amputation with silicone
liner after wound closure. Journal of International Medical
Research 2016;44(4):957–67.
Christiansen 2018 {published data only}
Christiansen CL, Miller MJ, Murray AM, Stephenson
RO, Stevens-Lapsley JE, Hiatt WR, et al. Behavior-
change intervention targeting physical function, walking,
and disability after dysvascular amputation: a randomized
controlled pilot trial. Archives of Physical Medicine and
Rehabilitation 2018;May 7:pii: S0003-9993(18)30284-3
[Epub ahead of print]. DOI: 10.1016/j.apmr.2018.04.011
Godfrey 1977 {published data only}
Godfrey CM, Brett R, Jousse AT. Foot mass and effect on
gait in the prosthetic limb. Archives of Physical Medicine and
Rehabilitation 1977;586(6):268–9.
Hafner 2015 {published data only}
Hafner BJ, Askew RL. Physical performance and self-report
outcomes associated with use of passive, adaptive, and active
prosthetic knees in persons with unilateral, transfemoral
amputation: randomized crossover trial. Journal of
Rehabilitation Research & Development 2015;52(6):677–99.
Imam 2015 {published data only}
Imam B, Miller WC, Finlayson H, Eng JJ, Jarus T. A
randomized controlled trial to evaluate the feasibility of the
Wii Fit for improving walking in older adults with lower
limb amputation. Clinical Rehabilitation 2015;31:82–92.
DOI: 10.1177/0269215515623601
Madsen 2017 {published data only}
Madsen UR, Hommel A, Berthelsen CB, Baath C.
Systematic review describing the effect of early mobilisation
after dysvascular major lower limb amputations. Journal of
Clinical Nursing 2017;26(21-22):3286–97.
Mandel 2016 {published data only}
Mandel A, Paul K, Paner R, Devlin M, Dilkas S, Pauley
T. Balance confidence and activity of community-
dwelling patients with transtibial amputation. Journal of
Rehabilitation Research & Development 2016;53(5):551–9.
Miller 2017 {published data only}
Miller MJ, Stevens-Lapsley J, Fields TT, Coons D, Bray-
Hall S, Sullivan W, et al. Physical activity behavior
change for older veterans after dysvascular amputation.
Contemporary Clinical Trials 2017;55:10–5.
Morgan 2016 {published data only}
Morgan SJ, Kelly VE, Amtmann D, Salem R, Hafner BJ.
Self-reported cognitive concerns in people with lower limb
loss. Archives of Physical Medicine and Rehabilitation 2016;
97(6):912–8.
NCT03296904 {published data only}
NCT03296904. The CYBERnetic lower-limb cognitive
ortho-prosthesis plus plus, 1st Clinical Study (CLs++1stCS).
clinicaltrials.gov/ct2/show/NCT03296904 (first received
29 September 2017).
NCT03376919 {published data only}
NCT03376919. The CYBERnetic lower limb cocognitive
ortho-prosthesis plus plus, 1st Clinical Study (CLs++).
clinicaltrials.gov/ct2/show/NCT03376919 (first received
19 December 2017).
NCT03433300 {published data only}
NCT03433300. Microprocessor knees in early
rehabilitation. clinicaltrials.gov/ct2/show/NCT03433300
(first received 14 February 2018).
Presern-Strukel 2000 {published data only}
Presern-Strukelj M, Poredos P. The influence of
electrostimulation on the circulation of the remaining leg in
patients with one-sided amputation. Angiology 2002;53(3):
329–35.
Samitier 2016 {published data only}
Samitier CB, Guirao L, Costea M, Camos JM, Pleguezuelos
E. The benefits of using a vacuum-assisted socket system to
improve balance and gait in elderly transtibial amputees.
Prosthetics and Orthotics International 2016;40(1):83–8.
Simanic 2015 {published data only}
Simnacic I, Popovic I, Jakovljevic V. Orthopedics prosthetic
rehabilitation of patients with unilateral lower limb
amputation and hyperbaric oxygenation. Prosthetics and
Orthotics International 2015;39:336–7.
12Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputation (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Wong 2002 {published data only}
Wong CK, Edelstein JE. Unna and elastic post operative
dressings: comparison of their effects on function of adults
with amputation and vascular disease. Archives of Physical
Medicine and Rehabilitation 2000;81(9):1191–8.
References to studies awaiting assessment
NCT03094208 {published data only}
NCT03094208. The effects of dual task balance training in
individuals with above knee amputation. clinicaltrials.gov/
ct2/show/NCT03094208 (first received 29 March 2017).
References to ongoing studies
NCT01942798 {published data only}
NCT01942798. Study of Wii Fit to enhance walking in
older adult amputees (WiiNWalk). clinicaltrials.gov/ct2/
show/NCT01942798 (first received 16 September 2013).
Additional references
Broomhead 2012
Broomhead P, Clark K, Dawes D, Hale C, Lambert A,
Quinlivan D, et al. Evidence based clinical guidelines
for the physiotherapy management of adults with lower
limb prostheses. Chartered Society of Physiotherapy. 2nd.
London, 2012.
Das Pooja 2013
Das Pooja G, Sangeeta L. Prevalence and aetiology of
amputation in Kolkata, India: a retrospective analysis. Hong
Kong Physiotherapy Journal 2013;31:36–40.
Davies 2003
Davies B, Datta D. Mobility outcome following unilateral
lower limb amputation. Prosthetics and Orthotics
International 2003;27(3):186–90.
Esquenazi 2004
Esquinazi A. Amputation rehabilitation and prosthetic
restoration. From surgery to community reintegration.
Disability and Rehabilitation 2004;26:831–6.
Guyatt 2008
Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an
emerging consensus on rating quality of evidence and
strength of recommendations. BMJ 2008;336((7650):
924–6.
HCUP Nationwide Inpatient Sample (NIS) 2009
Agency for Healthcare Research and Quality. Healthcare
Cost and Utilization Project (HCUP). 2009. Available
at www.hcup–us.ahrq.gov/overview.jsp (accessed 15
September 2018).
Higgins 2011
Higgins JP, Green S, editor(s). Cochrane Handbook
for Systematic Reviews of Interventions Version 5.1.0
(updated March 2011). The Cochrane Collaboration,
2011. Available from handbook.cochrane.org.
Houghton 1992
Houghton AD, Taylor PR, Thurlow S, Rootes E, McColl
I. Success rates for rehabilitation of vascular amputees:
implications for preoperative assessment and amputation
level. British Journal of Surgery 1992;79(8):753–5.
ISD 2004
Information and Statistics Division NHS Scotland. The
amputee statistical database for the United Kingdom 2002/
03. www.nasdab.co.uk/pdf.pl?file=nasdab/news/Intro.pdf
(accessed 12 October 2004).
LLS 2000
Limb Loss Statistics. Estimates of incidence (rate) of limb
loss and congenital limb absence in the United States.
amputee-coalition.org/limb-loss-resource-center/resources-
filtered/resources-by-topic/limb-loss-statistics/limb-loss-
statistics/ (accessed 28 September 2017).
Moxley 2010
Moxley PW, Hofman D, Hinchcliffe RJ. Epidemiological
study of lower limb amputation in England between 2003
and 2008. British Journal of Surgery 2010;97:1348–53.
Munin 2001
Munin MC, Espejo-De Guzman MC, Boninger ML,
Fitzgerald SG, Penrod LE, Singh J. Predictive factors
for successful early prosthetic ambulation among lower-
limb amputees. Journal of Rehabilitation Research and
Development 2001;38(4):379–84.
Roth 1998
Roth EJ, Park KL, Sullivan WJ. Cardiovascular disease in
patients with dysvascular amputation. Archives of Physical
Medicine and Rehabilitation 1998;79(2):205–15.
Waters 1976
Waters RL, Perry J, Antonelli D, Hislop H. Energy cost of
walking of amputees: the influence of level of amputation.
Journal of Bone and Joint Surgery 1976;58(1):42–6.
WHO 2001
World Health Organization. International Classification of
Functioning, Disability and Health (ICF). Geneva: World
Health Organization, 2001. [ISBN 9241545429. m]
Yigiter 2002
Yigiter K, Sener G, Erbahceci F, Bayer K, Ulger OG,
Akdogan S. A comparison of traditional prosthetic training
versus proprioceptive neuromuscular facilitation resistive
gait training with trans-femoral amputees. Prosthetics and
Orthotics International 2002;26:213–7.
Ziegler-Graham 2008
Ziegler-Graham K, MacKenzie EJ, Ephraim PL, Travison
TG, Brookmeyer R. Estimating the prevalence of limb loss
in the United States: 2005 to 2050. Archives of Physical
Medicine and Rehabilitation 2008;89(3):422–9.
References to other published versions of this review
Cumming 2006
Cumming J, Barr S, Howe TE. Prosthetic rehabilitation for
older dysvascular people following a unilateral transfemoral
amputation. Cochrane Database of Systematic Reviews 2006,
Issue 4. DOI: 10.1002/14651858.CD005260.pub2
13Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputation (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cumming 2015
Cumming J, Barr S, Howe TE. Prosthetic rehabilitation for
older dysvascular people following a unilateral transfemoral
amputation. Cochrane Database of Systematic Reviews 2015,
Issue 1. DOI: 10.1002/14651858.CD005260.pub3
Howe 2005
Howe TE, Cumming JCO, Barr S. Prosthetic rehabilitation
for older dysvascular people following a unilateral
transfemoral amputation. Cochrane Database of
Systematic Reviews 2005, Issue 2. DOI: 10.1002/
14651858.CD005260
∗ Indicates the major publication for the study
14Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputation (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Meikle 2003
Methods Study design: single-centre, randomised, double-blind cross-over trial
Exclusions post randomisation: none
Losses to follow-up: none
Participants Country: Canada
Setting: community
No. of participants: 10
Inclusion criteria: loss of limb due to PVD; over the age of 50; ambulant in the commu-
nity for a minimum of 3 months since amputation; independent community ambulator
with prosthesis with or without aids; ability to walk for 2 minutes consecutively
Exclusion criteria: cognitive impairment sufficient to limit ability to participate. Of 12
participants who were eligible for the study, 2 refused to participate
Interventions Single session assessment. Added weight to prosthetic limb below the knee: 150 g
(placebo) vs 770 g vs 1625 g
Duration: 1 day
Follow-up: none - single assessment only
Outcomes Primary: Two-Minute Walk Test
Secondary: participant preference in terms of weight applied
Notes No follow-up following the trial period
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quote: “weights were applied in random
order by a secondary investigator who was
not involved in any of the data collection”
Study authors made no mention of the
method used to randomise the sequence of
interventions
Allocation concealment (selection bias) High risk Quote: “weights were applied in random
order by a secondary investigator who was
not involved in any of the data collection”
Study authors made no mention of the
method used to conceal the allocation of
interventions
Blinding (performance bias and detection
bias)
All outcomes
Low risk Both participants and assessors were
blinded to the interventions
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Meikle 2003 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcome data were reported and anal-
ysed.
Selective reporting (reporting bias) Low risk Review authors found no evidence of selec-
tive reporting of study data
Other bias Low risk Review authors noted no other sources of
bias.
PVD: peripheral vascular disease
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Agrawal 2015 Population did not include unilateral transfemoral amputees.
Alexander 1978 Participants did not meet the inclusion criteria. Experimental group included only 1 transfemoral amputee
below the age of 60. Outcome measure selected was not used in prosthetic rehabilitation
Chin 2016 Wrong patient population: transtibial amputees
Christiansen 2018 Wrong intervention: study authors did not look at prosthetic rehabilitation
Godfrey 1977 Not a randomised or a quasi-randomised controlled trial
Hafner 2015 Wrong intervention: focused on the type of prosthetic component - not on rehabilitation
Imam 2015 Transfemoral and transtibial data were not supplied separately
Madsen 2017 Wrong study design: systematic review
Mandel 2016 Wrong patient population: transtibial amputees
Miller 2017 Wrong study design
Morgan 2016 Wrong intervention: study authors did not look at prosthetic rehabilitation
NCT03296904 Wrong intervention: focused on type of prosthetic component - not on rehabilitation
NCT03376919 Wrong intervention: focused on type of prosthetic component - not on rehabilitation
NCT03433300 Wrong intervention: focused on type of prosthetic component - not on rehabilitation
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(Continued)
Presern-Strukel 2000 Study authors did not look at prosthetic rehabilitation
Samitier 2016 Wrong study design: quasi-experimental before-and-after study
Simanic 2015 Participants did notmeet the inclusion criteria. Study population included individuals with diabetic gangrene,
vascular disease, and trauma; transfemoral and transtibial data were not supplied separately
Wong 2002 Investigators provided a pre-prosthetic rehabilitation intervention that falls outside the scope of this review
Characteristics of studies awaiting assessment [ordered by study ID]
NCT03094208
Methods Study name: The Effects of Dual Task Balance Training in Individuals With Above Knee Amputation
Randomised controlled trial
Participants Transfemoral amputees between 18 and 80 years of age
Interventions Dual task balance training (muscle strengthening, weight transfer, dual task balance exercises, dual task gait exercises)
vs traditional balance training (muscle strengthening, weight transfer, balance exercises, gait exercises)
Training takes 4 weeks and is provided 3 days a week.
Outcomes Gait speed (10-meter walk test)
Gait analysis (footprint method)
Cognition (Montreal Cognitive Assessment)
Depression (Beck Depression inventory)
Balance (1-leg stance test)
Balance (4-square step test)
Functional mobility (timed up and go test)
Notes Study is ongoing.
Study could be considered for inclusion in the future if we were able to extract data specifically for older adults
Characteristics of ongoing studies [ordered by study ID]
NCT01942798
Trial name or title Study of Wii Fit to Enhance Walking in Older Adult Amputees
Methods Randomised controlled trial
Participants Unilateral transfemoral or transtibial amputees over the age of 50
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NCT01942798 (Continued)
Interventions Active comparator: cognitive games
Wii Big Brain Academy Degree programme
Participants will receive the intervention for 40-minute sessions, 3×/week for 4 weeks. Interventions will be
administered as combination of onsite group training and individualised home-based training
Experimental: Wii.N.Walk intervention
Nintendo Wii
Participants will receive the intervention for 40-minute sessions, 3×/week for 4 weeks. Interventions will be
administered as combination of onsite group training and individualised home-based training
Outcomes Mini Mental State Examination (MMSE)
Two-Minute Walk Test (2MWT)
Short Physical Performance Battery (SPPB)
Walking While Talking Test (WWT)
Activities-specific Balance Confidence (ABC) Scale
Physical Activity Scale for the Elderly (PASE)
Four-Square Step Test (FSST)
Starting date April 2014
Contact information Bita Imam; bita.imam@alumni.ubc.ca
Notes
A P P E N D I C E S
Appendix 1. CENTRAL search strategy
Search run on Mon Jan 16 2017
#1 MESH DESCRIPTOR Arteriosclerosis 868
#2 MESH DESCRIPTOR Arteriolosclerosis EX-
PLODE ALL TREES
0
#3 MESH DESCRIPTOR Arteriosclerosis Oblit-
erans
71
#4 MESH DESCRIPTOR Atherosclerosis 619
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(Continued)
#5 MESHDESCRIPTOR Arterial Occlusive Dis-
eases
724
#6 MESHDESCRIPTOR Intermittent Claudica-
tion
712
#7 MESH DESCRIPTOR Ischemia 789
#8 MESH DESCRIPTOR Peripheral Vascular
Diseases EXPLODE ALL TREES
2201
#9 (atherosclero* or arteriosclero* or PVD or
PAOD or PAD ):TI,AB,KY
9119
#10 ((arter* or vascular or vein* or veno* or pe-
ripher*) near3 (occlus* or reocclus* or re-occlus*
or steno* or restenos* or obstruct* or lesio* or
block* or harden* or stiffen* or obliter*) ):TI,
AB,KY
7966
#11 (peripheral near3 dis*):TI,AB,KY 3371
#12 (claudic* or IC):TI,AB,KY 3063
#13 (isch* or CLI):TI,AB,KY 23713
#14 arteriopathic:TI,AB,KY 7
#15 dysvascular*:TI,AB,KY 10
#16 (leg near3 (occlus* or reocclus* or re-occlus*
or steno* or restenos* or obstruct* or lesio* or
block* or harden* or stiffen* or obliter*) ):TI,
AB,KY
95
#17 (limb near3 (occlus* or reocclus* or re-occlus*
or steno* or restenos* or obstruct* or lesio* or
block* or harden* or stiffen* or obliter*) ):TI,
AB,KY
145
#18 ((lower near3 extrem*) near3 (occlus* or reoc-
clus* or re-occlus* or steno* or restenos* or ob-
struct* or lesio* or block* or harden* or stiffen*
or obliter*) ):TI,AB,KY
77
#19 MESH DESCRIPTOR Leg EXPLODE ALL
TREES WITH QUALIFIERS BS
1107
#20 MESH DESCRIPTOR Iliac Artery 144
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(Continued)
#21 MESH DESCRIPTOR Popliteal Artery 278
#22 MESH DESCRIPTOR Femoral Artery 810
#23 MESH DESCRIPTOR Tibial Arteries 33
#24 (((femor* or iliac or popliteal or fempop* or
crural or poplite* or infrapopliteal or inguinal
or femdist* or inguinal or infrainquinal or tib-
ial) near3 (occlus* or reocclus* or re-occlus*
or steno* or restenos* or obstruct* or lesio* or
block* or harden* or stiffen* or obliter*) )):TI,
AB,KY
1157
#25 MESH DESCRIPTOR Gangrene EXPLODE
ALL TREES
62
#26 MESH DESCRIPTOR Diabetic Angiopathies
EXPLODE ALL TREES
2129
#27 gangren*:TI,AB,KY 307
#28 (diabet* near3 angio*):TI,AB,KY 1149
#29 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #
7 OR #8 OR #9 OR #10 OR #11 OR #12 OR
#13 OR #14 OR #15 OR #16 OR #17 OR #
18 OR #19 OR #20 OR #21 OR #22 OR #23
OR #24 OR #25 OR #26 OR #27 OR #28
45998
#30 MESH DESCRIPTOR Amputation
EXPLODE ALL TREES
313
#31 MESH DESCRIPTOR Amputees EXPLODE
ALL TREES
81
#32 (leg near3 amput*):TI,AB,KY 115
#33 (extrem* near3 amput*):TI,AB,KY 75
#34 (limb near3 amput*):TI,AB,KY 199
#35 exarticulat*:TI,AB,KY 0
#36 disarticulat*:TI,AB,KY 17
#37 transgeni*:TI,AB,KY 171
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#38 #30 OR #31 OR #32 OR #33 OR #34 OR #
35 OR #36 OR #37
792
#39 MESH DESCRIPTOR Artificial Limbs 108
#40 MESH DESCRIPTOR Joint Prosthesis EX-
PLODE ALL TREES
1612
#41 prosthe*:TI,AB,KY 9428
#42 (artificial near3 (leg or limb or low or extremity)
):TI,AB,KY
25
#43 MESH DESCRIPTOR Rehabilitation EX-
PLODE ALL TREES
16901
#44 rehabilit*:TI,AB,KY 26625
#45 #39 OR #40 OR #41 OR #42 OR #43 OR #
44
45906
#46 #29 AND #38 AND #45 73
#47 * NOT SR-PVD:CC AND 28/02/2015 TO
28/02/2017:DL
157820
#48 #46 AND #47 8
Appendix 2. Trial registries searches
ClinicalTrials.gov
33 studies found for: transfemoral amputation
World Health Organization International Clinical Trials Registry Platform
8 records for 8 trials found for: transfemoral amputation
ISRCTN Register
No results found for “transfemoral amputation”
Appendix 3. Database searches June 2018
Source Search strategy Hits retrieved
CENTRAL via CRSO #1 MESH DESCRIPTOR Arteriosclerosis 946
#2 MESH DESCRIPTOR Arteriolosclerosis EX-
PLODE ALL TREES 0
#3 MESH DESCRIPTOR Arteriosclerosis Obliter-
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ans 78
#4 MESH DESCRIPTOR Atherosclerosis 1055
#5 MESH DESCRIPTOR Arterial Occlusive Dis-
eases 817
#6 MESH DESCRIPTOR Intermittent Claudica-
tion 821
#7 MESH DESCRIPTOR Ischemia 1526
#8 MESH DESCRIPTOR Peripheral Vascular Dis-
eases 711
#9 (atherosclero* or arteriosclero* or PVD or PAOD
or PAD ):TI,AB,KY 11989
#10 ((arter* or vascular or vein* or veno* or pe-
ripher*) near3 (occlus* or reocclus* or re-occlus* or
steno* or restenos* or obstruct* or lesio* or block* or
harden* or stiffen* or obliter*) ):TI,AB,KY 10474
#11 (peripheral near3 dis*):TI,AB,KY 4773
#12 (claudic* or IC):TI,AB,KY 4031
#13 (isch* or CLI):TI,AB,KY 31615
#14 arteriopathic:TI,AB,KY 7
#15 dysvascular*:TI,AB,KY 20
#16 (leg near3 (occlus* or reocclus* or re-occlus* or
steno* or restenos* or obstruct* or lesio* or block*
or harden* or stiffen* or obliter*) ):TI,AB,KY 128
#17 (limb near3 (occlus* or reocclus* or re-occlus*
or steno* or restenos* or obstruct* or lesio* or block*
or harden* or stiffen* or obliter*) ):TI,AB,KY 213
#18 (lower near3 extrem*) near3 (occlus* or reoc-
clus* or re-occlus* or steno* or restenos* or obstruct*
or lesio* or block* or harden* or stiffen* or obliter*)
107
#19 MESH DESCRIPTOR Leg 2788
#20 MESH DESCRIPTOR Iliac Artery 158
#21 MESH DESCRIPTOR Popliteal Artery 300
#22 MESH DESCRIPTOR Femoral Artery 896
#23 MESH DESCRIPTOR Tibial Arteries 37
#24 ((femor* or iliac or popliteal or fempop* or crural
or poplite* or infrapopliteal or inguinal or femdist*
or inguinal or infrainquinal or tibial) near3 (occlus*
or reocclus* or re-occlus* or steno* or restenos* or
obstruct* or lesio* or block* or harden* or stiffen* or
obliter*) ):TI,AB,KY 1694
#25 MESH DESCRIPTOR Gangrene EXPLODE
ALL TREES 67
#26 MESH DESCRIPTOR Diabetic Angiopathies
EXPLODE ALL TREES 2802
#27 gangren*:TI,AB,KY 391
#28 (diabet* near3 angio*):TI,AB,KY 1249
#29 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #
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7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13
OR #14 OR #15 OR #16 OR #17 OR #18 OR #
19 OR #20 OR #21 OR #22 OR #23 OR #24 OR
#25 OR #26 OR #27 OR #28 60581
#30 MESH DESCRIPTOR Amputation EX-
PLODE ALL TREES 360
#31 MESH DESCRIPTOR Amputees EXPLODE
ALL TREES 97
#32 (leg near3 amput*):TI,AB,KY 154
#33 (extrem* near3 amput*):TI,AB,KY 116
#34 exarticulat*:TI,AB,KY 0
#35 disarticulat*:TI,AB,KY 24
#36 transgeni*:TI,AB,KY 213
#37 (limb near3 amput*):TI,AB,KY 343
#38 #30 OR #31 OR #32 OR #33 OR #34 OR #
35 OR #36 OR #37 1075
#39 MESH DESCRIPTOR Artificial Limbs 127
#40 MESH DESCRIPTOR Joint Prosthesis EX-
PLODE ALL TREES 1740
#41 prosthe*:TI,AB,KY 11543
#42 (artificial near3 (leg or limb or low or extremity)
):TI,AB,KY 28
#43 MESH DESCRIPTOR Rehabilitation EX-
PLODE ALL TREES 29098
#44 rehabilit*:TI,AB,KY 34988
#45 #39 OR #40 OR #41 OR #42 OR #43 OR #
44 64511
#46 #29 AND #38 AND #45 125
#47 01/01/2017 TO 14/06/2018:CD 285491
#48 #46 AND #47 11
Clinicaltrials.gov transfemoral amputation | Start date on or after 01/
01/2017 | Last update posted on or before 06/15/
2018
9
ICTRP Search Portal transfemoral amputation | Start date on or after 01/
01/2017 | Last update posted on or before 06/15/
2018
2
MEDLINE 1 ARTERIOSCLEROSIS/ 56445
2 exp ARTERIOLOSCLEROSIS/ 150
3 Arteriosclerosis Obliterans/ 3973
4 ATHEROSCLEROSIS/ 31164
5 Arterial Occlusive Diseases/ 26484
6 Intermittent Claudication/ 7594
7 ISCHEMIA/ 47531
8 exp Peripheral Vascular Diseases/ 50035
9 (atherosclero* or arteriosclero* or PVD or PAOD
or PAD).ti,ab. 171401
10 ((arter* or vascular or vein* or veno* or peripher*)
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adj3 (occlus* or reocclus* or re-occlus* or steno* or
restenos* or obstruct* or lesio* or block* or harden*
or stiffen* or obliter*)).ti,ab. 142921
11 (peripheral adj3 dis*).ti,ab. 37792
12 (claudic* or IC).ti,ab. 62023
13 (isch* or CLI).ti,ab. 345828
14 arteriopathic.ti,ab. 162
15 dysvascular*.ti,ab. 216
16 (leg adj3 (occlus* or reocclus* or re-occlus* or
steno* or restenos* or obstruct* or lesio* or block*
or harden* or stiffen* or obliter*)).ti,ab. 707
17 (limb adj3 (occlus* or reocclus* or re-occlus* or
steno* or restenos* or obstruct* or lesio* or block*
or harden* or stiffen* or obliter*)).ti,ab. 1805
18 (lower adj3 extrem* adj3 (occlus* or reocclus* or
re-occlus* or steno* or restenos* or obstruct* or lesio*
or block* or harden* or stiffen* or obliter*)).ti,ab.
1480
19 exp LEG/su [Surgery] 5038
20 Iliac Artery/ 13352
21 Popliteal Artery/ 8964
22 Femoral Artery/ 27058
23 Tibial Arteries/ 1484
24 ((femor* or iliac or popliteal or fempop* or crural
or poplite* or infrapopliteal or inguinal or femdist*
or inguinal or infrainquinal or tibial) adj3 (occlus*
or reocclus* or re-occlus* or steno* or restenos* or
obstruct* or lesio* or block* or harden* or stiffen* or
obliter*)).ti,ab. 9685
25 exp GANGRENE/ 7947
26 exp Diabetic Angiopathies/ 45387
27 gangren*.ti,ab. 15698
28 (diabet* adj3 angio*).ti,ab. 2405
29 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or
11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19
or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or
28 838651
30 exp AMPUTATION/ 19780
31 exp AMPUTEES/ 3073
32 (leg adj3 amput*).ti,ab. 1202
33 (extrem* adj3 amput*).ti,ab. 2761
34 (limb adj3 amput*).ti,ab. 5211
35 exarticulat*.ti,ab. 218
36 disarticulat*.ti,ab. 1467
37 transgeni*.ti,ab. 115853
38 or/30-37 143335
39 Artificial Limbs/ 6234
40 exp Joint Prosthesis/ 40671
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41 prosthe*.ti,ab. 111922
42 (artificial adj3 (leg or limb or low or extremity)).
ti,ab. 616
43 exp REHABILITATION/ 274914
44 rehabilit*.ti,ab. 144455
45 or/39-44 504799
46 29 and 38 and 45 1738
47 randomized controlled trial.pt. 464667
48 controlled clinical trial.pt. 92510
49 randomized.ab. 415972
50 placebo.ab. 190292
51 drug therapy.fs. 2030526
52 randomly.ab. 292859
53 trial.ab. 433053
54 groups.ab. 1809780
55 or/47-54 4235260
56 exp animals/ not humans.sh. 4474870
57 55 not 56 3661363
58 46 and 57 257
59 (2017* or 2018*).ed. 1446470
60 58 and 59 31
Embase 1 arteriosclerosis/ 33957
2 exp arteriolosclerosis/ 595
3 peripheral occlusive artery disease/ 33159
4 atherosclerosis/ 136005
5 peripheral occlusive artery disease/ 33159
6 intermittent claudication/ 9753
7 ischemia/ 76563
8 exp peripheral vascular disease/ 1657628
9 (atherosclero* or arteriosclero* or PVD or PAOD
or PAD).ti,ab. 235882
10 ((arter* or vascular or vein* or veno* or peripher*)
adj3 (occlus* or reocclus* or re-occlus* or steno* or
restenos* or obstruct* or lesio* or block* or harden*
or stiffen* or obliter*)).ti,ab. 196809
11 (peripheral adj3 dis*).ti,ab. 54205
12 (claudic* or IC).ti,ab. 62544
13 (isch* or CLI).ti,ab. 500348
14 arteriopathic.ti,ab. 205
15 dysvascular*.ti,ab. 239
16 (leg adj3 (occlus* or reocclus* or re-occlus* or
steno* or restenos* or obstruct* or lesio* or block*
or harden* or stiffen* or obliter*)).ti,ab. 987
17 (limb adj3 (occlus* or reocclus* or re-occlus* or
steno* or restenos* or obstruct* or lesio* or block*
or harden* or stiffen* or obliter*)).ti,ab. 2660
18 (lower near3 extrem* adj3 (occlus* or reocclus*
or re-occlus* or steno* or restenos* or obstruct* or
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lesio* or block* or harden* or stiffen* or obliter*)).
ti,ab. 0
19 exp leg/su [Surgery] 8660
20 iliac artery/ 14573
21 popliteal artery/ 8505
22 femoral artery/ 30203
23 tibial artery/ 2623
24 ((femor* or iliac or popliteal or fempop* or crural
or poplite* or infrapopliteal or inguinal or femdist*
or inguinal or infrainquinal or tibial) adj3 (occlus*
or reocclus* or re-occlus* or steno* or restenos* or
obstruct* or lesio* or block* or harden* or stiffen* or
obliter*)).ti,ab. 14004
25 exp gangrene/ 10875
26 exp diabetic angiopathy/ 12013
27 gangren*.ti,ab. 18519
28 (diabet* adj3 angio*).ti,ab. 3407
29 or/1-28 2052432
30 exp amputation/ 43014
31 exp amputee/ 523
32 (leg adj3 amput*).ti,ab. 1452
33 (leg adj3 amput*).ti,ab. 1452
34 (limb adj3 amput*).ti,ab. 6843
35 exarticulat*.ti,ab. 247
36 disarticulat*.ti,ab. 1733
37 transgeni*.ti,ab. 147153
38 or/30-37 193556
39 limb prosthesis/ 3285
40 exp joint prosthesis/ 62957
41 prosthe*.ti,ab. 132403
42 (artificial adj3 (leg or limb or low or extremity)).
ti,ab. 726
43 exp rehabilitation/ 346472
44 rehabilit*.ti,ab. 203634
45 or/39-44 621858
46 29 and 38 and 45 2196
47 randomized controlled trial/ 506330
48 controlled clinical trial/ 460965
49 random$.ti,ab. 1311150
50 randomization/ 78484
51 intermethod comparison/ 235763
52 placebo.ti,ab. 273660
53 (compare or compared or comparison).ti. 470243
54 ((evaluated or evaluate or evaluating or assessed
or assess) and (compare or compared or comparing
or comparison)).ab. 1755056
55 (open adj label).ti,ab. 64646
56 ((double or single or doubly or singly) adj (blind
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or blinded or blindly)).ti,ab. 209275
57 double blind procedure/ 150748
58 parallel group$1.ti,ab. 21840
59 (crossover or cross over).ti,ab. 93056
60 ((assign$ or match or matched or allocation) adj5
(alternate or group$1 or intervention$1 or patient$1
or subject$1 or participant$1)).ti,ab. 283339
61 (assigned or allocated).ti,ab. 332397
62 (controlled adj7 (study or design or trial)).ti,ab.
295531
63 (volunteer or volunteers).ti,ab. 224702
64 trial.ti. 251606
65 or/47-64 4042810
66 46 and 65 300
67 (2017* or 2018*).em. 3577308
68 66 and 67 51
69 from 68 keep 1-51 51
CINAHL S60 S58 AND S59 14
S59 EM 2017 OR EM 2018 363,970
S58 S44 AND S57 163
S57 S45 OR S46 OR S47 OR S48 OR S49 OR S50
OR S51 OR S52 OR S53 OR S54 OR S55 OR S56
341,446
S56 MH “Placebos” 8,351
S55 MH “Random Assignment” 38,557
S54 MH “Single-Blind Studies” or MH “Double-
Blind Studies” or MH “Triple-Blind Studies” 32,692
S53 MH “Crossover Design” 11,188
S52 MH “Factorial Design” 919
S51 MH “Clinical Trials” 93,051
S50 TX “multi-centre study” OR “multi-center
study” OR “multicentre study” OR “multicenter
study” OR “multi-site study” 4,468
S49 TX crossover OR “cross-over” 14,532
S48 AB placebo* 28,242
S47 TX random* 218,592
S46 TX trial* 249,926
S45 TX “latin square” 142
S44 S28 AND S36 AND S43 540
S43 (TX rehabilit*:) AND (S37 OR S38 OR S39
OR S40 OR S41 OR S42) 187,865
S42 TX rehabilit*: 187,865
S41 (MH “Rehabilitation+”) 186,200
S40 TX artificial n3 (leg or limb or low or extremity)
253
S39 TX prosthe* 34,777
S38 (MH “Joint Prosthesis+”) 4,078
S37 (MH “Limb Prosthesis”) 1,376
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S36 S29 OR S30 OR S31 OR S32 OR S33 OR S34
OR S35 9,167
S35 TX transgeni* 1,964
S34 TX disarticulat* 338
S33 TX exarticulat* 7
S32 TX extrem* n3 amput* 1,069
S31 TX leg n3 amput* 317
S30 (MH “Amputees”) 1,940
S29 (MH “Amputation+”) 5,215
S28 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7
OR S8 OR S9 OR S10 OR S11 OR S12 OR S13
OR S14 OR S15 OR S16 OR S17 OR S18 OR S19
OR S20 OR S21 OR S22 OR S23 OR S24 OR S25
OR S26 OR S27 95,405
S27 TX diabet* n3 angio* 1,748
S26 TX gangren* 1,314
S25 (MH “Diabetic Angiopathies+”) 9,730
S24 (MH “Gangrene”) 365
S23 TX (femor* or iliac or popliteal or fempop*
or crural or poplite* or infrapopliteal or inguinal or
femdist* or inguinal or infrainquinal or tibial) n3 (oc-
clus* or reocclus* or re-occlus* or steno* or restenos*
or obstruct* or lesio* or block* or harden* or stiffen*
or obliter*) 1,102
S22 (MH “Tibial Arteries”) 146
S21 (MH “Femoral Artery”) 1,208
S20 (MH “Popliteal Artery”) 363
S19 (MH “Iliac Artery”) 460
S18 (MH “Leg/SU”) 258
S17 TX (lower n3 extrem*) n3 (occlus* or reocclus*
or re-occlus* or steno* or restenos* or obstruct* or
lesio* or block* or harden* or stiffen* or obliter*)
122
S16 TX limb n3 (occlus* or reocclus* or re-occlus*
or steno* or restenos* or obstruct* or lesio* or block*
or harden* or stiffen* or obliter* 274
S15 TX leg n3 (occlus* or reocclus* or re-occlus* or
steno* or restenos* or obstruct* or lesio* or block*
or harden* or stiffen* or obliter*) 123
S14 TX dysvascular* 172
S13 TX arteriopathic 10
S12 TX isch* or CLI 39,373
S11 TX claudic* or IC 5,850
S10 TX peripheral n3 dis* 9,241
S9 TX (arter* or vascular or vein* or veno* or pe-
ripher*) n3 (occlus* or reocclus* or re-occlus* or
steno* or restenos* or obstruct* or lesio* or block*
or harden* or stiffen* or obliter*) 12,648
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S8 TX atherosclero* or arteriosclero* or PVD or
PAOD or PAD 26,344
S7 (MH “Peripheral Vascular Diseases+”) 10,398
S6 (MH “Ischemia”) 3,367
S5 (MH “Intermittent Claudication”) 852
S4 (MH “Arterial Occlusive Diseases”) 1,607
S3 (MH “Arteriosclerosis”) 4,829
S2 (MH “Arteriosclerosis+”) 17,789
S1 (MH “Arteriosclerosis”) 4,829
AMED 1 arteriosclerosis/ 78
2 atherosclerosis/ 221
3 intermittent claudication/ 73
4 ischemia/ 263
5 exp peripheral vascular disease/ 118
6 ((arter* or vascular or vein* or veno* or peripher*)
adj3 (occlus* or reocclus* or re-occlus* or steno* or
restenos* or obstruct* or lesio* or block* or harden*
or stiffen* or obliter*)).ti,ab. 458
7 (peripheral adj3 dis*).ti,ab. 435
8 (claudic* or IC).ti,ab. 1024
9 (isch* or CLI).ti,ab. 1666
10 arteriopathic.ti,ab. 1
11 dysvascular*.ti,ab. 57
12 (leg adj3 (occlus* or reocclus* or re-occlus* or
steno* or restenos* or obstruct* or lesio* or block*
or harden* or stiffen* or obliter*)).ti,ab. 21
13 (limb adj3 (occlus* or reocclus* or re-occlus* or
steno* or restenos* or obstruct* or lesio* or block*
or harden* or stiffen* or obliter*)).ti,ab. 32
14 (lower near3 extrem* adj3 (occlus* or reocclus*
or re-occlus* or steno* or restenos* or obstruct* or
lesio* or block* or harden* or stiffen* or obliter*)).
ti,ab. 0
15 [exp leg/su [Surgery]] 0
16 ((femor* or iliac or popliteal or fempop* or crural
or poplite* or infrapopliteal or inguinal or femdist*
or inguinal or infrainquinal or tibial) adj3 (occlus*
or reocclus* or re-occlus* or steno* or restenos* or
obstruct* or lesio* or block* or harden* or stiffen* or
obliter*)).ti,ab. 109
17 gangren*.ti,ab. 86
18 (diabet* adj3 angio*).ti,ab. 14
19 or/1-18 3850
20 exp Amputation/ 2066
21 (leg adj3 amput*).ti,ab. 81
22 (extrem* adj3 amput*).ti,ab. 205
23 (limb adj3 amput*).ti,ab. 684
24 exarticulat*.ti,ab. 0
0
29Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputation (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
25 disarticulat*.ti,ab. 131
26 transgeni*.ti,ab. 48
27 or/20-26 2323
28 Artificial limbs/ 338
29 exp Joint prosthesis/ 639
30 prosthe*.ti,ab. 2628
31 (artificial adj3 (leg or limb or low or extremity)).
ti,ab. 31
32 exp Rehabilitation/ 54176
33 rehabilit*.ti,ab. 25009
34 or/28-33 62822
35 19 and 27 and 34 118
36 exp CLINICAL TRIALS/ 3749
37 RANDOM ALLOCATION/ 314
38 DOUBLE BLIND METHOD/ 657
39 Clinical trial.pt. 1211
40 (clinic* adj trial*).tw. 5381
41 ((singl* or doubl* or trebl* or tripl*) adj (blind*
or mask*)).tw. 2833
42 PLACEBOS/ 586
43 placebo*.tw. 3102
44 random*.tw. 17520
45 PROSPECTIVE STUDIES/ 1097
46 or/37-45 22515
47 35 and 46 7
48 (“2017” or “2018”).yr. 2075
49 47 and 48 0
WH A T ’ S N E W
Date Event Description
16 August 2018 New citation required but conclusions have not changed New searches run. No new studies included, 14 new
studies excluded, one study ongoing, and one study
awaiting classification. No changes to conclusions
16 August 2018 New search has been performed New searches run. No new studies included, 14 new
studies excluded, one study ongoing, and one study
awaiting classification. Review amended to reflect cur-
rent Cochrane standards. ’Summary of findings’ table
added
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H I S T O R Y
Protocol first published: Issue 2, 2005
Review first published: Issue 4, 2006
Date Event Description
11 December 2014 New search has been performed New searches run. No new included studies. Minor
text changes made
11 December 2014 New citation required but conclusions have not
changed
New searches run. No new included studies. No
changes to conclusions
4 October 2010 New search has been performed CENTRAL search amended and re-run. No new trials
found
28 October 2008 New search has been performed Searches re-run. No new trials found
23 May 2008 Amended Review converted to new review format
30 April 2007 Amended Minor copyedits made to correct incomplete last sen-
tence in Authors’ conclusions and to correct Acknowl-
edgements. Search dates updated. No changes to con-
clusions
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
For this update, we have assessed the included study for bias by using Cochrane’s ’Risk of bias’ tool as described in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011). We have updated additional methods sections to reflect current
Cochrane standards and have added a ’Summary of findings’ table.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Amputation [methods; ∗rehabilitation]; Artificial Limbs [∗psychology]; Femur [∗surgery]; Leg [blood supply; surgery]; Patient Satis-
faction; Randomized Controlled Trials as Topic
MeSH check words
Aged; Humans; Middle Aged
32Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputation (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
